Did Unrecognized Cardiac Amyloidosis Hinder Recent HFpEF Trials? ...Middle East

Medscape - News
Routinely screening for cardiac amyloid and excluding those patients might increase the chances of finding efficacious treatments for heart failure with preserved ejection fraction, researchers suggest. Medscape Medical News

Hence then, the article about did unrecognized cardiac amyloidosis hinder recent hfpef trials was published today ( ) and is available on Medscape ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Did Unrecognized Cardiac Amyloidosis Hinder Recent HFpEF Trials? )

Apple Storegoogle play

Last updated :

Also on site :